Clinical Trials Directory

Trials / Terminated

TerminatedNCT03983720

Can Fatigability Neuromuscular Explain Chronic Fatigue in People With Multiple Sclerosis?

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
67 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Chronic fatigue is the most common and debilitating symptom in multiple sclerosis patients. This chronic fatigue affects their quality of life by decreasing their capacity to perform simple tasks of daily life. The aim of the present project is to determine whether deteriorated neuromuscular function (i.e. increased fatigability) is involved in this feeling of chronic fatigue. Because the causes of this feeling are multi-dimensional, a large battery of tests will allow us to better understand the origin of chronic fatigue. A better knowledge of chronic fatigue etiology will allow to optimize rehabilitation treatments to decrease the apparition/persistence of chronic fatigue and in fine improve quality of life.

Conditions

Interventions

TypeNameDescription
OTHEREvaluation of degree chronic fatigue.Evaluation of degree chronic fatigue with the results of survey Fatigue Severity Scale (FSS) and Modified Fatigue Impact Scale (MFIS). This result will allow to divide patients in groups : lowly fatigued and highly fatigued.
OTHERQuestionnaires* Fatigue Severity Scale (FSS) * Modified Fatigue Impact Scale (MFIS) * Godin Leisure-Time Exercise Questionnaire (GLTEQ) * Scale of life quality of multiple sclerosis (SEP-59) * Center for Epidemiologic Studies Depression (CES-D) * Pittsburgh Sleep Quality Index (PSQ-I)
BIOLOGICALBlood sampleBlood sample will be realized to evaluate anemia and inflammations.
OTHERCardiopulmonary evaluationCardiopulmonary evaluation will be realized with a cycle ergometer.
DEVICECapacity of muscular oxygen extractionMeasure the capacity of muscular oxygen extraction with a cycle ergometer.
DEVICESleep assessmentSleep assessment will be measured by actigraphy during 15 days.
DEVICEMetabolic fatigueMetabolic fatigue will be measured by Magnetic Resonance Imaging (MRI).
OTHERNeuromuscular evaluationNeuromuscular evaluation will be measured by the composite of the results of: * Fatigue test * Measure of voluntary isometric force * Surface electromyography * Peripheral nerve stimulation * Transcranial Magnetic Stimulation (TMS) * Perceived fatigue * Cognitive fatigue * Thermoregulation

Timeline

Start date
2020-01-21
Primary completion
2021-06-16
Completion
2021-07-31
First posted
2019-06-12
Last updated
2023-11-02

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03983720. Inclusion in this directory is not an endorsement.